tiprankstipranks
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
OKUR
OnKure Therapeutics
RESEARCH TOOLSreports

OnKure Therapeutics (OKUR) Income Statement

436 Followers

OnKure Therapeutics Income Statement

Last quarter (Q4 2025), OnKure Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, OnKure Therapeutics's net income was $-13.50M. See OnKure Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -830.00K$ 0.00$ 0.00$ 0.00$ -50.00K
Operating Expenses
$ 62.12M$ 54.39M$ 36.93M$ 29.77M$ 39.77M
Depreciation and Amortization
$ 830.00K$ 662.00K$ 560.00K$ 387.00K$ 50.00K
EBITDA
$ -62.12M$ -51.71M$ -34.75M$ -29.38M$ -39.72M
Operating Income
$ -62.95M$ -54.39M$ -36.93M$ -29.77M$ -39.82M
Other Income/Expenses
$ 3.43M$ 1.71M$ 1.62M$ 254.00K$ 48.00K
Pretax Income
$ -59.52M$ -52.67M$ -35.31M$ -29.51M$ -39.77M
Net Income
$ -59.52M$ -52.67M$ -35.31M$ -29.51M$ -39.77M
Per Share Metrics
Basic EPS
$ -4.40$ -3.95$ -2.65$ -2.21$ -21.92
Diluted EPS
$ -4.40$ -3.95$ -2.65$ -2.21$ -21.92
Weighted Average Shares Outstanding
 13.52M 13.34M 13.34M 13.34M 1.81M
Weighted Average Shares Outstanding (Diluted)
 13.52M 13.34M 13.34M 13.34M 1.81M
Currency in USD

OnKure Therapeutics Earnings and Revenue History